Our prior work in murine neurons demonstrated CHI3L1's neurotoxic effects,4 prompting us to explore its impact on MS patient‐derived human induced pluripotent stem cells (hiPSC). The gene discussed is CHI3L1; the disease is myeloid sarcoma.